Where I see patients (5)
Selected research
-
Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy.
Transplantation and cellular therapy
-
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
Pediatric blood & cancer
-
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.
Pediatric blood & cancer
Clinical trials
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Seve...
The median time to failure or death will be compared on the two arms using the log-rank test. Failure of IST is defined as the date that a second definitive therapy was recommended (BMT, second course of ATG) and failure of BMT de...
Recruiting
More about this studyTreosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatmen...
The primary endpoint is the incidence of 1-year GVHD free, EFS (GEFS). An event is defined as death due to any cause, primary or secondary graft failure/rejection, or 2nd HCT whichever occurs first. Grade III-IV acute GVHD and chr...
Recruiting
More about this studyStudy to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thr...
Durable platelet response is defined as a proportion of participants able to achieve platelet counts at or above 50,000/μL for ≥ two-thirds of at least 8 non-missing weekly scheduled platelet measurements during the last 12 weeks ...
Recruiting
More about this studyContact me
Stress-free visits
Accommodations. Admissions. Procedure prep. Get the info you need for smoother hospital stays.
Prepare for your child's stay![](/-/media/project/ucsf/ucsf-bch/images/by-your-side-moment/seal/bys_footer_seal-attentive-2x.jpg?rev=ab7ebfda2443469ca8f9c38e227e1beb&hash=B70395F30E790D00C96C9D75007D94EE)